Skip to the content
-
-
Fortress Biotech’s Subsidiary Cyprium Therapeutics Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $205 Million
-
Fulton Financial Corporation and Blue Foundry Bancorp Announce Regulatory Approvals and Anticipated Merger Closing Date
-
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion
-
FULTON FINANCIAL CORPORATION AND BLUE FOUNDRY BANCORP ANNOUNCE REGULATORY APPROVALS AND ANTICIPATED MERGER CLOSING DATE
-
Bitmine Immersion Technologies anuncia que sus tenencias de ETH alcanzan los 4.423 millones de tokens
-
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Western Asset High Income Opportunity Fund Inc. Announces Financial Position as of December 31, 2025
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Compass Diversified Announces Appointment of Eric Weis as President of PrimaLoft; Elevation of Shawn Neville to PrimaLoft Board Chair
-
ACORE CAPITAL Announces Closing of $1.1 Billion Commercial Real Estate CLO
-
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
-
Avenue Therapeutics Enters into Exclusive Worldwide License Agreement for ATX-04 for the Treatment of Pompe Disease
-
Outdoor Holding Company Reaches Settlement with Digital Cash Processing
-
Where Will We Get the Energy?
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds for the Months of March, April and May 2026
-
Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to their Managed Distribution Policy for the Months of March, April and May 2026